The back story: Elan and Biogen have a joint agreement over multiple sclerosis drug Tysabri, a likely $1 billion blockbuster. Elan did a $1 billion financing deal with Johnson & Johnson that gives J&J ...
DUBLIN, Ireland--(BUSINESS WIRE)--Jan. 12, 2005--Elan Corporation, plc today announced that its proprietary NanoCrystal(R) technology is being used by Johnson & Johnson Pharmaceutical Research & ...
Elan sold Tysabri to Biogen Idec for $3.25 billion.--Courtesy of Elan Some shareholders started grumbling that they would like to get their hands on the windfall as soon as they learned Elan would ...
In this article, we will be taking a look at the 10 Best Pharma Stocks to Buy According to Billionaires. Elanco Animal Health Incorporated is one of them. Elanco Animal Health Incorporated (NYSE:ELAN) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback